A Rational Approach to Tumour Imaging in the Abdomen

  • S. C. Rankin
Conference paper
Part of the Syllabus book series (SYLLABUS)


Multiple modalities are now available for the investigation of abdominal tumours. It is increasingly important to select the most appropriate investigation based on availability and local expertise. Tests which appear to be very expensive may be the most useful if they prevent unnecessary surgery or expensive chemotherapy. Tumour assessment can be divided into 4 stages:
  1. 1.


  2. 2.


  3. 3.

    Response to treatment

  4. 4.

    Recurrence of disease



Positron Emission Tomography Renal Cell Cancer Oesophageal Cancer Tumour Image Adrenal Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Adler LP, Crowe JP, al-Kaisi NK, et al. (1993) Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology 187:743–750PubMedGoogle Scholar
  2. Boland GW, Hahn PF, Pena C, Mueller PR (1997) Adrenal masses: characterisation with delayed contrast enhanced CT. Radiology 202:693–696PubMedGoogle Scholar
  3. Di Chiro G (1987) Positron emission tomography using [18F] fluorodeoxyglucose in brain tumours. A powerful diagnostic and prognostic tool. Invest Radiol 22:360–371PubMedCrossRefGoogle Scholar
  4. Glazer HS, Lee JKT, Levitt RG, et al. (1985) Radiation fibrosis: differentiation from recurrent tumour by MR imaging. Radiology 156:721PubMedGoogle Scholar
  5. Hill M, Cunningham D, MacVicar D, et al. (1993) Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma. J Clin Oncol 11:2273PubMedGoogle Scholar
  6. Husband JES, Reznek RH (1998) Imaging in oncology. Isis Medical, OxfordGoogle Scholar
  7. Korbkin M, Lombardi TJ, Aisen AM, et al. (1995) Characterization of adrenal metastases with chemical shift and gadolinium-enhanced MR imaging. Radiology 197:411–418Google Scholar
  8. Lewis P, Griffin S, Marsden P, et al. (1994) Whole body 18F-fluorodeoxyglucose positron emission tomography in the preoperative evaluation of lung cancer. Lancet 344:1265–1266PubMedCrossRefGoogle Scholar
  9. Newman JS, Francis IR, Kaminski MS, et al. (1994) Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 190:111–116PubMedGoogle Scholar
  10. Nieweg OE, Pruim J, van Ginkel RJ et al. (1996) Fluorine-18-fluorodeoxyglucose PET in soft tissue sarcoma. J Nucl Med 37:257–261PubMedGoogle Scholar
  11. Rankin SC, Taylor H, Cook GJR, Mason R (1998) Computerised tomography and positron emission tomography in the preoperative staging of oesophageal cancer. Clin Radiol 53:659–665PubMedCrossRefGoogle Scholar
  12. Rege S, Maass A, Chaiken L, et al. (1994) Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck tumours. Cancer 74:3047–3058CrossRefGoogle Scholar
  13. Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32:623–648PubMedGoogle Scholar
  14. Steinert HC, Huch Boni RA, Buck A et al. (1995) Malignant melanoma: staging with whole body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 195:705–709Google Scholar
  15. Warburg O (1931) The metabolism of tumors. Richard R. Smith, New York, pp 129–169Google Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • S. C. Rankin
    • 1
  1. 1.Department of RadiologyGuy’s HospitalLondonUK

Personalised recommendations